Systematic review / meta-analysis / 2024
Higher serum vitamin B12 concentrations were linked to an increased risk of all-cause mortality, especially in older adults.
A systematic review and dose-response meta-analysis of 22 cohort studies (92,346 individuals, 10,704 all-cause deaths) evaluated serum vitamin B12 levels and mortality risk. Each 100 pmol/L increase in serum vitamin B12 was associated with a 4% higher risk of all-cause mortality in the general population (adjusted HR 1.04, 95% CI 1.01 to 1.08) and a 6% higher risk in older adults (adjusted HR 1.06, 95% CI 1.01 to 1.13). High concentrations (>600 pmol/L) were linked to all-cause mortality (adjusted HR 1.50, 95% CI 1.29 to 1.74) and CVD mortality (adjusted HR 2.04, 95% CI 0.99 to 4.19), but not cancer mortality (adjusted HR 1.56, 95% CI 0.82 to 2.95). Evidence was mixed for cardiovascular mortality and limited for cancer mortality.
Shows an association, not proof of cause and effect.
- Study type
- Systematic review and dose-response meta-analysis
- Who was studied
- 92,346 individuals across 22 cohort studies (10,704 all-cause deaths)
- What was measured
- All-cause, cardiovascular, and cancer mortality
THE PAPER
The origin of vitamin B12 levels and risk of all-cause, cardiovascular and cancer specific mortality: A systematic review and dose-response meta-analysis.
Liu K, Yang Z, Lu X, Zheng B, Wu S, Kang J, Sun S, Zhao J. Arch Gerontol Geriatr, 2024.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.